Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.

Jerome Goldstein1, Paul T Tiseo, Kenneth S Albert

  • 1San Francisco Headache Clinic, 909 Hyde Street, Suite 322, San Francisco, CA 94109, USA.

Headache
|July 27, 2006
PubMed
Summary

Patients dissatisfied with rizatriptan found eletriptan 40 mg effective for migraine relief. Switching to eletriptan improved headache response and associated symptoms, offering a viable alternative treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in gene editing tools for four typical Gram-positive bacteria.

Frontiers in microbiology·2026
Same author

Privacy-Preserving Virtual Contrast-enhanced MRI for Nasopharyngeal Carcinoma: A Multi-center Study.

International journal of radiation oncology, biology, physics·2026
Same author

Prenatal Exposure to PFOA Induces Ovarian Function Impairment via the Disruption of the PPARγ/ANGPTL4 Pathway.

Environment & health (Washington, D.C.)·2026
Same author

Shorebird loss increases soil CO<sub>2</sub> emissions in coastal wetlands under restoration.

Fundamental research·2026
Same author

Case Report: A new <i>UBA2</i> variant in a Chinese family with aplasia cutis congenita.

Frontiers in medicine·2026
Same author

Unveiling the role of CtDREB1B from safflower: enhancing plant resistance to drought and salt.

BMC plant biology·2026

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine treatment efficacy varies significantly between individuals.
  • Triptans are not interchangeable; patients may benefit from switching agents within the class.

Purpose of the Study:

  • To evaluate the efficacy of switching patients with unsatisfactory rizatriptan response to eletriptan 40 mg.
  • To assess eletriptan's effectiveness in patients previously dissatisfied with rizatriptan.

Main Methods:

  • Open-label study of 123 migraine patients with prior unsatisfactory rizatriptan response.
  • Patients received eletriptan 40 mg at migraine onset.
  • Data collected on headache response, associated symptoms, and functional impairment.

Main Results:

Related Experiment Videos

  • 64% headache response at 2 hours; 63% functional response.
  • Significant improvements in nausea, photophobia, and phonophobia.
  • Eletriptan reduced functional impairment by 27-40%; 78% reported overall satisfaction.

    • Conclusions:

    • Eletriptan 40 mg is an effective treatment option for migraine patients dissatisfied with rizatriptan.
    • Switching to eletriptan can improve treatment outcomes for non-responders.